Long COVID-19
📧 Sign up to get email alerts when something new happens for Long COVID-19.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-11Clinical Trial Results: RECOVER-NEURO: Platform Protocol, Appendix_A to Measure the Effects of BrainHQ, PASC CoRE and tDCS Interventions on Long COVID Symptoms [NA]
A completed clinical trial evaluating brain stimulation and cognitive interventions (BrainHQ, tDCS) for Long COVID symptoms; results posted.
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: NENCA Study on Neurological Complications of Long COVID-19 in Children and Adolescents; Neurophysiological, Electroencephalographic and Neuroradiological Investigation [NA]
A clinical trial investigating neurological complications of Long COVID-19 in children and adolescents, utilizing neurophysiological, EEG, a…
-
CLINICAL_TRIALS research · 2025-03-07Clinical Trial Update: Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia
ClinicalTrials.gov lists a study evaluating pharyngeal electrostimulation therapy for acute neurogenic dysphagia, currently recruiting. The …
-
CLINICAL_TRIALS trial_result · 2023-12-12Clinical Trial Update: IMMUNERECOV CONTRIBUTES TO IMPROVEMENT OF RESPIRATORY AND IMMUNOLOGICAL RESPONSE IN POST-COVID-19 PATIENTS. [Phase 3]
Phase 3 trial update on Immunerecov contributing to improvement in respiratory and immunological response in post-COVID-19 patients (Long Co…
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: Pilot Study Into LDN and NAD+ for Treatment of Patients With Post-COVID-19 Syndrome [Phase 2]
A Phase 2 pilot study investigating LDN and NAD+ for post-COVID-19 syndrome has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.